We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CGI
GIB
$15.3B
| $3.85M | 0.02% |
44,753
-9,477
| -17% | -$781K |
|
752
TFI International
TFII
$12B
| $3.85M | 0.02% |
38,379
+15,358
| +67% | +$1.53M |
|
753
Unifirst Corp
UNF
$5.24B
| $3.84M | 0.02% |
19,879
-3,978
| -17% | -$728K |
|
|
DCPH
754
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.83M | 0.02% |
233,699
-49,649
| -18% | -$807K |
|
755
Walmart Inc
WMT
$923B
| $3.81M | 0.02% |
+80,676
| New | +$3.83M |
|
756
Newmark Group
NMRK
$2.68B
| $3.81M | 0.02% |
478,330
+36,190
| +8% | +$302K |
|
|
NSTG
757
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.78M | 0.02% |
474,399
+156,507
| +49% | +$1.36M |
|
758
World Kinect Corp
WKC
$1.89B
| $3.77M | 0.02% |
138,120
-53,068
| -28% | -$1.43M |
|
759
Ingevity
NGVT
$2.62B
| $3.77M | 0.02% |
53,461
-8,656
| -14% | -$610K |
|
760
Xometry
XMTR
$5.34B
| $3.72M | 0.02% |
115,269
-56,440
| -33% | -$2.64M |
|
761
Axos Financial
AX
$5.68B
| $3.71M | 0.02% |
96,948
+4,569
| +5% | +$174K |
|
762
NOV
NOV
$7.45B
| $3.68M | 0.02% |
176,094
+104,259
| +145% | +$2.19M |
|
763
Global Ship Lease
GSL
$1.49B
| $3.68M | 0.02% |
220,926
-126,814
| -36% | -$2.18M |
|
764
Harley-Davidson
HOG
$2.7B
| $3.66M | 0.02% |
88,099
+58,934
| +202% | +$2.51M |
|
765
Canadian Pacific Kansas City
CP
$81.5B
| $3.66M | 0.02% |
49,060
+36,762
| +299% | +$2.77M |
|
766
Immunovant
IMVT
$8.8B
| $3.65M | 0.02% |
+205,834
| New | +$2.59M |
|
767
CDW
CDW
$17.1B
| $3.64M | 0.02% |
20,410
-20,744
| -50% | -$3.65M |
|
768
Broadridge
BR
$19.3B
| $3.63M | 0.02% |
27,056
-14,609
| -35% | -$2.08M |
|
769
IQVIA
IQV
$39.8B
| $3.63M | 0.02% |
+17,708
| New | +$3.59M |
|
770
Philips
PHG
$26.2B
| $3.62M | 0.02% |
281,908
-596,449
| -68% | -$7.19M |
|
771
Huazhu Hotels Group
HTHT
$12.7B
| $3.61M | 0.02% |
+85,001
| New | +$3.07M |
|
772
Virtu Financial
VIRT
$5.04B
| $3.59M | 0.02% |
176,072
+127,196
| +260% | +$2.76M |
|
773
Polaris
PII
$3.9B
| $3.59M | 0.02% |
+35,560
| New | +$3.7M |
|
774
Patrick Industries
PATK
$2.79B
| $3.59M | 0.02% |
88,785
-43,820
| -33% | -$1.52M |
|
775
Minerals Technologies
MTX
$2.25B
| $3.58M | 0.02% |
58,917
-19,833
| -25% | -$1.12M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.